At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ISRG Intuitive Surgical
Market Closed 09-11 16:00:00 EDT
369.15
+8.69
+2.41%
盘后369.11
-0.04-0.01%
19:58 EDT
High374.48Low363.56Vol3.35M
Open363.56D1 Closing360.46Amplitude3.03%
Mkt Cap130.86BTradable Cap129.67BTotal Shares354.50M
T/O1.24BT/O Rate0.95%Tradable Shares351.26M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Intuitive Surgical EVP, Chief Manufacturing and Supply Chain Mark Brosius Sells USD 17,138.39 in Shares
Reuters  ·  09-12 06:41
Intuitive Surgical EVP, Chief Manufacturing and Supply Chain Mark Brosius Sells USD 17,138.39 in Shares
Movement Alert｜Intuitive Surgical Rises 3.11% in Regular Trading, Earnings Call Signals Higher Overseas Lease Rates and New Growth Catalysts
Market Focus  ·  09-11 21:33
Movement Alert｜Intuitive Surgical Rises 3.11% in Regular Trading, Earnings Call Signals Higher Overseas Lease Rates and New Growth Catalysts
Intuitive Surgical Inc. Stock Outperforms Competitors on Strong Trading Day
Dow Jones  ·  09-11 04:38
Intuitive Surgical Inc. Stock Outperforms Competitors on Strong Trading Day
Intuitive Surgical EVP and Chief Manufacturing and Supply Chain Mark Brosius Sells USD 24,222.38 in Common Shares
Reuters  ·  09-10
Intuitive Surgical EVP and Chief Manufacturing and Supply Chain Mark Brosius Sells USD 24,222.38 in Common Shares
Intuitive Surgical Exec Says Co's US Business Which Accounts for About 60% of Its Operations, is Decelerating - Conf Call
THOMSON REUTERS  ·  09-09
Intuitive Surgical Exec Says Co's US Business Which Accounts for About 60% of Its Operations, is Decelerating - Conf Call
Intuitive Surgical Exec Says Co's Growth Drivers are Expected to Remain Broadly Consistent in 2026 Compared with the Prior Year - Conf Call
THOMSON REUTERS  ·  09-09
Intuitive Surgical Exec Says Co's Growth Drivers are Expected to Remain Broadly Consistent in 2026 Compared with the Prior Year - Conf Call
Intuitive Surgical Exec Says U.S. Bariatrics is Just over 2% of Global Da Vinci Procedures, with Its Incremental Impact Moderating over Time - Conf Call
THOMSON REUTERS  ·  09-09
Intuitive Surgical Exec Says U.S. Bariatrics is Just over 2% of Global Da Vinci Procedures, with Its Incremental Impact Moderating over Time - Conf Call
Intuitive Surgical Exec Says Planned 2027 Extended-Use Instrument Program Could Provide a Tailwind to Procedure Growth as Investors Weigh Slowing U.S. Growth - Conf Call
THOMSON REUTERS  ·  09-09
Intuitive Surgical Exec Says Planned 2027 Extended-Use Instrument Program Could Provide a Tailwind to Procedure Growth as Investors Weigh Slowing U.S. Growth - Conf Call
Intuitive Surgical Exec Says Co Expects Leasing Rates for Systems Outside the United States to 'Progressively Increase over Time' - Conf Call
THOMSON REUTERS  ·  09-09
Intuitive Surgical Exec Says Co Expects Leasing Rates for Systems Outside the United States to 'Progressively Increase over Time' - Conf Call
Intuitive Surgical Inc. Stock Underperforms Tuesday When Compared to Competitors
Dow Jones  ·  09-09
Intuitive Surgical Inc. Stock Underperforms Tuesday When Compared to Competitors
New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
GlobeNewswire  ·  09-09
New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
Intuitive Surgical Inc Stock (ISRG) Moved Down by 4.38% on Sep 8: Drivers Behind the Movement
TradingKey  ·  09-09
Intuitive Surgical Inc Stock (ISRG) Moved Down by 4.38% on Sep 8: Drivers Behind the Movement
Movement Alert｜Intuitive Surgical Falls 3.13% in Regular Trading, Trading at $355.955
Market Focus  ·  09-08
Movement Alert｜Intuitive Surgical Falls 3.13% in Regular Trading, Trading at $355.955
Intuitive Surgical Price Target Maintained with a $469.00/Share by BTIG
Dow Jones  ·  09-08
Intuitive Surgical Price Target Maintained with a $469.00/Share by BTIG
Roubini's Split Verdict: Four Risks Overhead, A "Real Global Investment Boom" Underneath
Analyst Calls  ·  09-08
Roubini's Split Verdict: Four Risks Overhead, A "Real Global Investment Boom" Underneath
Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Tyra Bioscience (TYRA)
TIPRANKS  ·  09-08
Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Tyra Bioscience (TYRA)
The 5% Reckoning: It's Washington's Deficit, Not Big Tech's Leverage, That Pops The AI Bubble
Analyst Calls  ·  09-07
The 5% Reckoning: It's Washington's Deficit, Not Big Tech's Leverage, That Pops The AI Bubble
Kospi Down 27%, Goldman Still Says 12,000: "The Market Is Underpricing This Cycle"
Analyst Calls  ·  09-07
Kospi Down 27%, Goldman Still Says 12,000: "The Market Is Underpricing This Cycle"
No AI, No Interview: UBS Rewrites Wall Street's Ticket In
AI Industry Frontlines  ·  09-07
No AI, No Interview: UBS Rewrites Wall Street's Ticket In
$14 Billion On The Seabed: Big Tech Is Taking Over The World's Data Railroads
AI Industry Frontlines  ·  09-03
$14 Billion On The Seabed: Big Tech Is Taking Over The World's Data Railroads

Introduction

Company Name.
Intuitive Surgical
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Issue price:
--